Remsleep Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Remsleep Holdings Inc in the first quarter 2026?
Due to the lack of equity, it was not possible to calculate Remsleep Holdings Inc 's return on equity (ROE) in its first quarter 2026

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Equity Change	-	-	-90.48 %	-60.65 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-3	-3	-3	-1	-1
Return On Equity (TTM)	-	-4042.47 %	-1788.41 %	-398.29 %	-267.61 %
RMSL's Total Ranking	# 4008	# 3491	# 3309	# 3249	# 2895
Equity (TTM) in Millions	0	0	0	0	0
Seq. Equity Change	-	-	-87.14 %	78.09 %	-44.27 %
Seq. Net Income Change	-	-	-	-	-

Back to RMSL Management Effectiveness >> RMSL's 5 Years Annual ROE >> Compare RMSL ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 25
Sector	# 445
Overall	# 4008

Return On Equity Statistics
High	Average	Low
-38.11 %	-542.05 %	-4316.09 %
(Sep 30 2022)		(Mar 31 2026)

News about Remsleep Holdings Inc Return on Equity ROE

DELTAWAVE Nasal Pillows System: Pioneering Comfort and Precision in Sleep Apnea Treatment

Introducing the DELTAWAVE Nasal Pillows System: A Revolution in Sleep Apnea Treatment
In a bold move, REMSleep Holdings Inc. recently announced its strategic marketing plan for the highly anticipated DELTAWAVE Nasal Pillows System. This groundbreaking product has the potential to revolutionize the way sleep apnea is treated, providing individuals suffering from the condition a more comfortable and effective solution.
Sleep apnea is a serious sleep disorder that affects millions of people worldwide. Those afflicted with the condition experience pauses in breathing during sleep, often resulting in excessive daytime sleepiness, irritability, and even heart problems in severe cases. Continuous Positive Airway Pressure (CPAP) therapy has long been the gold standard treatment for sleep apnea, involving a mask that delivers pressurized air to keep the airways open. However, many patients find this solution uncomfortable, leading to poor compliance rates.

RMSL Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	0	0	1	3	3
Y / Y Equity Change	-90.48 %	-63.82 %	-65.64 %	3.43 %	-
Net Income in Millions	-3	-1	-2	-1	-4
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-9420.19 %	-320.16 %	-191.02 %	-54.88 %	-146.09 %

Back to RMSL Management Effectiveness >> RMSL's 5 Years Annual ROE >> Compare RMSL ROE to its Competitors

More Return On Equity Ratios
Personal Services Industry Roe Trends and Statistics
Services Sector Return On Equity Statistics
RMSL's' Return on Equity at Yahoo Finance
RMSL's Roe Ratio versus Personal Services Industry, Services Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RMSL's Competitors
Subscribers only: Roe for Remsleep Holdings Inc 's Suppliers
Subscribers only: Return On Equity for RMSL's Customers

Companies with similar Return On Equity at Mar 31 2026, within Services Sector

ROE

Date modified: 2026-09-12T06:22:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.